简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

OSR Holdings shares are trading higher after its unit Vaximm entered a non-binding term sheet with BCM Europe to explore a potential exclusive global licensing agreement for its VXM01 oral cancer immunotherapy platform.

2025-11-21 22:26

OSR Holdings shares are trading higher after its unit Vaximm entered a non-binding term sheet with BCM Europe to explore a potential exclusive global licensing agreement for its VXM01 oral cancer immunotherapy platform.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。